A new survey has examined the impact of diagnosis delays in the most prominent neurological disorders: Alzheimer’s (AD), Parkinson’s (PD) and Multiple Sclerosis (MS). The survey, commissioned by GE Healthcare and conducted by Praxis Research, Inc., reflects opinions of physicians and patients in the US, UK, Germany and France. A total of 240 physicians, consisting of hospital and office-based neurologists and psychiatrists (UK-only) participated. A total of 101 patients with Multiple Sclerosis, Parkinson’s disease or Alzheimer’s disease participated. So what did the survey show? That we have a lot of work to do.